Code | 9781C | ||||||||||
MA number | EU/1/18/1264/001 | ||||||||||
Product Form: | tbl flm 60x30 mg (fľ.HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Takeda Pharma A/S, Denmark | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.11.2018 |
SmPC + PL: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 18.08.2023 |